BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...
Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...
A scientific poster session showcasing successful CTSC-connected research ... should include a faculty member from Case Western Reserve University (CWRU), Cleveland Clinic, MetroHealth Medical Center, ...
Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...
Interested contributors have until 2 May 2025 to submit abstracts for scientific posters ... medical physicists, medical radiation technologists and regulatory authorities. Contributors interested in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results